The Seattle-based biotech company will use the funding in its efforts to kill cancerous tumors using the same immune system response pathway that fights the flu.
Read more
The Seattle-based biotech company will use the funding in its efforts to kill cancerous tumors using the same immune system response pathway that fights the flu.
Comments are closed.